...
首页> 外文期刊>Molecular pharmaceutics >A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut
【24h】

A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut

机译:一种新颖的局部回收机制,可增强类黄酮的肠道生物利用度并延长其在肠道中的停留时间

获取原文
获取原文并翻译 | 示例
           

摘要

Recycling in the gastrointestinal tract is important for endogenous substances such as bile acids and for xenobiotics such as flavonoids. Although both enterohepatic and enteric recycling mechanisms are well recognized, no one has discussed the third recycling mechanism for glucuronides: local recycling. The intestinal absorption and metabolism of wogonin and wogonoside (wogonin-7-glucuronide) was characterized by using a four-site perfused rat intestinal model, and hydrolysis of wogonoside was measured in various enzyme preparations. In the perfusion model, the wogonoside and wogonin were interconverted in all four perfused segments. Absorption of wogonoside and conversion to its aglycon at the upper small intestine was inhibited in the presence of a glucuronidase inhibitor (saccharolactone) but was not inhibited by lactase phlorizin hydrolase (LPH) inhibitor gluconolactone or antibiotics. Further investigation indicated that hydrolysis of wogonoside in the blank intestinal perfusate was not correlated with bacterial counts. Kinetic studies indicated that K m values from blank duodenal and jejunal perfusate were essentially identical to the K m values from intestinal S9 fraction but were much higher (2-fold) than those from the microbial enzyme extract. Lastly, jejunal perfusate and S9 fraction share the same optimal pH, which was different from those of fecal extract. In conclusion, local recycling of wogonin and wogonoside is the first demonstrated example that this novel mechanism is functional in the upper small intestine without significant contribution from bacteria β-glucuronidase.
机译:对于内源性物质(例如胆汁酸)和异生物质(例如黄酮类),胃肠道的回收很重要。尽管肠肝和肠的循环利用机制都得到了公认,但没有人讨论过葡糖苷酸的第三个循环利用机制:局部循环利用。使用四点灌流大鼠肠道模型表征了伍格宁和伍格诺糖苷(伍格宁-7-葡萄糖醛酸苷)的肠道吸收和代谢,并在各种酶制剂中测定了伍格苷的水解。在灌注模型中,在所有四个灌注段中,wogonoside和wogonin相互转换。在葡糖醛酸糖苷酶抑制剂(蔗糖内酯)的存在下,抑制了窝草皂苷的吸收并在小肠上转化为糖苷配基,但未被乳糖酶Phrizrizin水解酶(LPH)抑制剂葡糖酸内酯或抗生素所抑制。进一步的研究表明,空白肠灌流液中的wogonoside的水解与细菌数无关。动力学研究表明,空白十二指肠和空肠灌注液的K m值与肠道S9部分的K m值基本相同,但比微生物酶提取物的K m值高得多(> 2倍)。最后,空肠灌流液和S9组分具有相同的最佳pH,这与粪便提取物的pH不同。总之,沃戈宁和沃戈甙的局部回收是第一个证明的例子,该新机制在上小肠中起作用,而细菌β-葡萄糖醛酸苷酶没有显着贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号